The University of Southampton
University of Southampton Institutional Repository

Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus

Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus
Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus
Background Sodium cromoglicate (SCG) has long been used in the management of allergic diseases, including as an ointment for atopic dermatitis. Although mast cell stabilization was initially considered as its mechanism of action, anti-inflammatory actions and modulation of sensory nerve function have also been suggested.

Objectives To investigate the mechanism(s) by which SCG relieves allergen- and histamine-induced dermal inflammation by assessing its effects on pruritus, flare, skin temperature and weal volume.

Methods Aqueous cream containing 0·2%, 1% or 4% SCG or no SCG (placebo) was applied in a randomized single-blind manner to four areas on each forearm (two sites per arm) and covered with an occlusive dressing. One hour later, skin-prick tests were performed in 20 allergic subjects with allergens to which they had previously shown sensitization, and in 40 nonallergic subjects with codeine (9 mg mL?1, 20 subjects) and histamine (10 mg mL?1, 20 subjects). Weal volume, skin temperature increase, erythema area and pruritus intensity were assessed at 0, 5, 10 and 15 min.

Results SCG significantly (P < 0·05 to P < 0·001) reduced pruritus induced by all stimuli, with 4% SCG being most effective. Significant (P < 0·05 to P < 0·01) reductions of erythema area were also seen but there was no inhibition of weal volume or temperature increase.

Conclusions SCG is effective in reducing pruritus but has no effect on weals, supporting the proposition that, in the skin, SCG inhibits sensory C-fibre nerve activation rather than preventing mast cell degranulation. We suggest that topical SCG treatment, delivered in an appropriate vehicle, may be beneficial for symptomatic relief of pruritus in patients with cutaneous mastocytosis and other pruritic dermatoses.
dermal allergy, pruritus, skin prick test, sodium cromoglicate, urticaria
674-676
Vieira dos Santos, R
c15fa28d-6b32-4f85-9473-0c1cd8dc1e5b
Magerl, M
63cd858d-cd9f-4393-959a-1ff64f707445
Martus, P
90c4bc91-da1b-40a2-b2b2-0d288d81c4df
Zuberbier, T
5c3351fa-5b32-411e-a4ff-768a54fa3a91
Church, MK
235f8b3a-20fd-4096-81b7-25c468eb9ef6
Vieira dos Santos, R
c15fa28d-6b32-4f85-9473-0c1cd8dc1e5b
Magerl, M
63cd858d-cd9f-4393-959a-1ff64f707445
Martus, P
90c4bc91-da1b-40a2-b2b2-0d288d81c4df
Zuberbier, T
5c3351fa-5b32-411e-a4ff-768a54fa3a91
Church, MK
235f8b3a-20fd-4096-81b7-25c468eb9ef6

Vieira dos Santos, R, Magerl, M, Martus, P, Zuberbier, T and Church, MK (2009) Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. British Journal of Dermatology, 162 (3), 674-676. (doi:10.1111/j.1365-2133.2009.09516.x).

Record type: Article

Abstract

Background Sodium cromoglicate (SCG) has long been used in the management of allergic diseases, including as an ointment for atopic dermatitis. Although mast cell stabilization was initially considered as its mechanism of action, anti-inflammatory actions and modulation of sensory nerve function have also been suggested.

Objectives To investigate the mechanism(s) by which SCG relieves allergen- and histamine-induced dermal inflammation by assessing its effects on pruritus, flare, skin temperature and weal volume.

Methods Aqueous cream containing 0·2%, 1% or 4% SCG or no SCG (placebo) was applied in a randomized single-blind manner to four areas on each forearm (two sites per arm) and covered with an occlusive dressing. One hour later, skin-prick tests were performed in 20 allergic subjects with allergens to which they had previously shown sensitization, and in 40 nonallergic subjects with codeine (9 mg mL?1, 20 subjects) and histamine (10 mg mL?1, 20 subjects). Weal volume, skin temperature increase, erythema area and pruritus intensity were assessed at 0, 5, 10 and 15 min.

Results SCG significantly (P < 0·05 to P < 0·001) reduced pruritus induced by all stimuli, with 4% SCG being most effective. Significant (P < 0·05 to P < 0·01) reductions of erythema area were also seen but there was no inhibition of weal volume or temperature increase.

Conclusions SCG is effective in reducing pruritus but has no effect on weals, supporting the proposition that, in the skin, SCG inhibits sensory C-fibre nerve activation rather than preventing mast cell degranulation. We suggest that topical SCG treatment, delivered in an appropriate vehicle, may be beneficial for symptomatic relief of pruritus in patients with cutaneous mastocytosis and other pruritic dermatoses.

This record has no associated files available for download.

More information

Published date: 24 September 2009
Keywords: dermal allergy, pruritus, skin prick test, sodium cromoglicate, urticaria

Identifiers

Local EPrints ID: 145649
URI: http://eprints.soton.ac.uk/id/eprint/145649
PURE UUID: 6e2f70db-34e8-4d38-be1b-ffec1ba92dca

Catalogue record

Date deposited: 19 Apr 2010 13:26
Last modified: 14 Mar 2024 00:51

Export record

Altmetrics

Contributors

Author: R Vieira dos Santos
Author: M Magerl
Author: P Martus
Author: T Zuberbier
Author: MK Church

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×